AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

COBRA BIOMANUFACTURING (CBF).

Investors Chronicle

| January 12, 2007 | COPYRIGHT 2007 FT Business. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

"We've achieved what we set out to achieve," says Cobra's executive chairman Peter Fothergill, having announced a return to profitability after a tough two years. The biopharmaceutical manufacturer had a turbulent time after the bottom fell out of the plasmid DNA market and biotech customers in Europe struggled to attract investment. But refocusing on protein-based biopharmaceuticals and the US market has paid off handsomely. North American revenues rose 41 per cent in the year to GBP8.7m, while turnover from protein products roughly ...

Related articles from newspapers, magazines, journals, and more
Phase III Medical Announces Appointment of Harvard's Dr. Wayne Marasco as...
Press release article from: Business Wire November 23, 2004 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM...Marasco joined the Board of Directors of Phase III Medical in June 2003. He is an Associate...biographical information on Dr. Marasco and Phase III Medical, please refer to the Company...
Neurocrine Biosciences Ramps Up Phase III Clinical Trials for NBI-34060 In...
Press release article from: PR Newswire March 19, 2002 700+ words
...is initiating three additional pivotal Phase III clinical trials of NBI-34060 Immediate...1200 patients. The Company's first Phase III study with NBI-34060-IR was previously...currently be conducting four of eight planned Phase III clinical trials with NBI-34060. According...
CMS Releases Stark Phase III Regulations.(United States. Centers for Medicare...
News wire article from: Mondaq Business Briefing September 4, 2007 700+ words
...copy of the long-awaited Stark II Phase III Regulations. Overall, healthcare providers should be pleased with the Phase III Stark rules. Despite fears that...would be drastically altered, the Phase III revisions are for the most part...
Phase III Medical Completes Acquisition of NeoStem, Inc., an Adult Stem Cell...
Press release article from: Business Wire January 26, 2006 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (Phase III) (OTCBB:PHSM), has completed the acquisition of...stem cells. Pursuant to the terms of the acquisition, Phase III, through its wholly owned subsidiary, has purchased...
Pain Therapeutics Announces Fourth Quarter and Year End 2004 Financial Results;...
Press release article from: PR Newswire January 26, 2005 700+ words
...We ended the year with three drugs in Phase III clinical trials, nearly $100 million...results now set the stage for a series of Phase III clinical announcements in 2005. After...look forward to unblinding data from our Phase III trials and announcing clinical results...
Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache...
Press release article from: Business Wire September 11, 2008 700+ words
-- Phase III Studies Show Statistically Significant...completed a top-line analysis of its two Phase III clinical trials exploring the use of...pleased with the top-line results of our Phase III clinical trials which show that BOTOX...
InterMune Provides Update on Its Two Phase III Pulmonology Programs.
Press release article from: PR Newswire October 17, 2005 700+ words
- Phase III INSPIRE Trial on Track to Conclude Around the End of 2007 - - Design of Phase III Pirfenidone Program Finalized - - Company...Inc. today provided an update on its two Phase III programs evaluating two separate compounds...
Pain Therapeutics Completes Patient Enrollment for Phase III Study with...
Press release article from: PR Newswire September 8, 2004 700+ words
...successfully completed enrollment in a Phase III study of over 700 patients with severe...delighted patient enrollment for this pivotal Phase III study is on-time and on-budget...or osteoarthritic pain. Oxytrex is in Phase III clinical studies. What is Our Clinical...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA